Table of contents What’s new Supporting the development of medicines and vaccines Advice on clinical trials Monitoring the impact on…

Supporting the rapid development and approval of effective and safe treatments for and vaccines against COVID-19 is EMA’s top priority…

During an extraordinary virtual meeting held on 2 April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how the…

PRAC starts review of certain ifosfamide cancer medicines At its monthly meeting, EMA’s safety committee (PRAC) has started a review…